GABRIELLE'S ANGEL FOUNDATION FOR C… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1996

Legal Domicile

Principal Officer

DENISE RICH

Phone

6468612033

Tax Period

2023-01-01 to 2023-12-31

GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH INC, founded in 1996, is a community nonprofit in the Philanthropy & Grantmaking sector that reported $3.6M in total revenue in fiscal year 2023. Revenue surged 47% from the prior year, signaling strong growth momentum.

Mission

THE PURPOSE OF GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH, INC. (THE "FOUNDATION") IS TO ENCOURAGE THE DEVELOPMENT OF MORE EFFECTIVE THERAPIES FOR PATIENTS WITH LEUKEMIA, LYMPHOMA AND RELATED CANCERS. THE FOUNDATION FUNDS INNOVATIVE CLINICAL OR BASIC SCIENCE RESEARCH THAT WILL LEAD TO NOVEL THERAPEUTIC APPROACHES THAT COULD REPLACE, OR BE USED IN COMBINATION WITH, EXISTING EFFECTIVE THERAPIES. SUCH THERAPEUTIC APPROACHES COULD INCLUDE INTEGRATIVE (INTEGRATIVE / COMPLEMENTARY) MEDICINE. THE FOUNDATION FUNDS RESEARCH TO IMPROVE THE EFFICENCY OF CANCER TREATMENTS, REDUCE THEIR TOXICITY AND IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH LEUKEMIA OR LYMPHOMA. THE FOUNDATION ALSO SUPPORTS LIMITED SCIENTIFIC INTERCHANGE BETWEEN SELECT LEADERS IN DIFFERENT AREAS OF BIO AND INTEGRATIVE MEDICAL RESEARCH TO DEVELOP UNIQUE AND IMPORTANT COLLABORATIVE EFFORTS THAT WILL LEAD TO IMPROVEMENTS IN THE TREATMENT AND CARE OF PATIENTS WITH LEUKEMIA AND LYMPHOMA.

Program Service Accomplishments

Program 1

Expenses: $3,284,192

FOUNDATION FUNDS INNOVATIVE CLINICAL OR BASIC SCIENCE RESEARCH THAT WILL LEAD TO NOVEL THERAPEUTIC APPROACHES THAT COULD REPLACE, OR BE USED IN COMBINATION WITH EXISTING EFFECTIVE THERAPIES FOR...

FOUNDATION FUNDS INNOVATIVE CLINICAL OR BASIC SCIENCE RESEARCH THAT WILL LEAD TO NOVEL THERAPEUTIC APPROACHES THAT COULD REPLACE, OR BE USED IN COMBINATION WITH EXISTING EFFECTIVE THERAPIES FOR PATIENTS WITH LEUKEMIA, LYMPHOMA AND RELATED CANCERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $3,504,879

Program Service Revenue $0

Investment Income $256,284

Other Revenue $-136,137

TOTAL REVENUE $3,625,026

Expense Breakdown

Grants Paid $2,703,500

Salaries & Benefits $485,643

Fundraising Expenses $164,799

Program Expenses $3,284,192

Other Expenses $433,629

TOTAL EXPENSES $3,622,772

Year-over-Year Comparison

	2023	2022	Change
Revenue	$3,625,026	$2,464,150	+0.5%
Expenses	$3,622,772	$1,897,102	+0.9%
Net Income	$2,254	$567,048	-1.0%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$197,776

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DENISE RICH	PRESIDENT & CO-FOUNDER	3.00	Officer Director	$0	$0	$0
BROOKE MILLSTEIN	VICE CHAIR	3.00	Officer Director	$0	$0	$0
STAR JONES	DIRECTOR	3.00	Director	$0	$0	$0
PATRICIA QUICK	DIRECTOR	3.00	Director	$0	$0	$0
MICHELE RELLA	DIRECTOR	3.00	Director	$0	$0	$0
ILONA RICH SCHACHTER	DIRECTOR	1.00	Director	$0	$0	$0
THOMAS C QUICK	DIRECTOR	3.00	Director	$0	$0	$0
DANIELLA RICH KILSTOCK	DIRECTOR	3.00	Director	$0	$0	$0
PAUL SCHINDLER	DIRECTOR	3.00	Director	$0	$0	$0
LORRAINE E SCHWARTZ	DIRECTOR	3.00	Director	$0	$0	$0
STEPHEN D NIMER MD	DIRECTOR	3.00	Director	$0	$0	$0
JENNIFER RANIERI	EXECUTIVE DIRECTOR	40.00	Officer	$197,776	$0	$197,776
MICHELE KEENE	DIRECTOR OF DEVELOPMENT	40.00	Highest	$179,158	$0	$179,158

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$3,625,026	$3,622,772	$6,114,423	$2,254
2022	$2,464,150	$1,897,102	$5,133,948	$567,048
2021	$2,400,812	$2,727,907	$5,237,050	$-327,095
2020	$1,122,508	$2,200,110	$4,721,277	$-1,077,602
2019	$3,131,288	$2,031,721	$5,964,326	$1,099,567
2018	$2,510,040	$2,961,377	$5,333,248	$-451,337

GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH INC